Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Iterum Therapeutics plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 15 | 18 | +3 |
| Shares | 431.6K | 2.04M | +1.61M (+372.9%) |
| Value | $494.7K | $2.22M | +$1.73M (+349.6%) |
New holders (8)
Institutions that held Iterum Therapeutics plc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,340,000 | $1.46M | 0.04% |
| Alpine Global Management, LLC | 64,833 | $70.7K | 0.02% |
| XTX Topco Ltd | 33,040 | $36.0K | 0.00% |
| Two Sigma Securities, LLC | 14,947 | $16.3K | 0.00% |
| Geode Capital Management, LLC | 12,370 | $13.5K | 0.00% |
| Cypress Capital Management LLC (WY) | 66 | $72 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13 | $14 | 0.00% |
| JPMorgan Chase & Co | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held Iterum Therapeutics plc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Renaissance Technologies LLC | 64,022 | $73.3K |
| Susquehanna International Group, LLP | 38,483 | $44.6K |
| Kelly Financial Services LLC | 120 | $137 |
| Tower Research Capital LLC (TRC) | 100 | $114 |
| Advisor Group Holdings, Inc. | 12 | $13 |